BioCentury
ARTICLE | Financial News

Atossa Genetics completes follow-on

March 31, 2017 7:31 PM UTC

Drug delivery and cancer company Atossa Genetics Inc. (NASDAQ:ATOS) raised $4 million through the sale of 664,000 class A units at $0.75 and 3,502 class B units at $1,000 in a follow-on underwritten b...

BCIQ Company Profiles

Atossa Therapeutics Inc.